- ►prsjournal.com G Weigert, S Michels, S Sacu, A Varga, F … - British Journal of Ophthalmology, 2008 - bjo.bmj.com Results: In the bevacizumab-treated group mean visual acuity (VA) improved to a
2.2 line gain at 6 months follow-up. Eyes treated in the PDT plus IVTA group had
a stable mean VA at month 6 compared with baseline. There was a ... Cited by 27 - Related articles - BL Direct - All 7 versions
ZF Bashshur, A Schakal, RN Hamam, CP El … - Archives of Ophthalmology, 2007 - archopht.highwire.org Methods Patients with predominantly classic CNV were prospectively randomized to
receive standard PDT or intravitreal bevacizumab injections (2.5 mg).
Best-corrected visual acuity (BCVA) measured by Snellen charts, central ... Cited by 19 - Related articles - BL Direct - All 3 versions
A Melamud, S Stinnett, S Fekrat - American Journal of Ophthalmology, 2008 - Elsevier A total of 36 patients (37 eyes) received a series of three consecutive monthly
intravitreal injections of bevacizumab. Twenty (54%) of 37 eyes had no previous
treatments for neovascular AMD in the eye that received bevacizumab. ... Cited by 11 - Related articles - All 13 versions
- ►duanessolution.com BT SMITH, MS DHALLA, GK SHAH, KJ … - Retina, 2008 - journals.lww.com From *Barnes Retina Institute, St. Louis, Missouri; the †Department of
Ophthalmology and Visual Sciences, Washington University School of Medicine, St.
Louis, Missouri; ‡the Retina Group of Florida, Ft. Lauderdale, Florida; ... Cited by 14 - Related articles - All 5 versions
R Lazic, N Gabric - Ophthalmology, 2007 - Elsevier One hundred sixty-five eyes in 165 subjects (53 males, 112 females) aged between
60 and 87 years (mean [standard deviation]: 75.7 [6.0] years) were randomly
assigned to receive either a single PDT session with verteporfin (PDT ... Cited by 59 - Related articles - All 24 versions
A Mirshahi, R Roohipoor, A Lashay, SF … - European journal of ophthalmology - ncbi.nlm.nih.gov PURPOSE: To evaluate the additional therapeutic effect of single intravitreal
bevacizumab injection on standard laser treatment in the management of
proliferative diabetic retinopathy. METHODS: A prospective, fellow-eye sham ... Cited by 12 - Related articles - BL Direct
RA Costa, R Jorge, D Calucci, LAS Melo, JA … - Graefe's Archive for Clinical and Experimental …, 2007 - Springer Abstract Background A novel alternative for combined treatment using verteporfin
photodynamic therapy (PDT) has emerged as preliminary safety and efficacy data
of the intravitreal use of the anti-angiogenic bevacizumab became ... Cited by 31 - Related articles - BL Direct - All 3 versions
R Hahn, S Sacu, S Michels, A Varga, G … - Der Ophthalmologe: Zeitschrift der Deutschen …, 2007 - ncbi.nlm.nih.gov AIM: The aim of this study was to compare intravitreal bevacizumab (IVB) and
verteporfin therapy in combination with 4 mg intravitreal triamcinolone
(PDT-IVTA) in patients with neovascular age-related macular degeneration ... Cited by 8 - Related articles
CA Cleary, S Jungkim, K Ravikumar, C … - Eye, 2007 - nature.com A total of 112 eyes of 111 patients received injections. Median follow-up was 5
months (range: 1–12 months). Mean log MAR vision pre-injection was 0.84 0.03
(n=112); at 3 months was 0.69 0.05 (P<0.0001, n=84); at 6 months was 0.74 ... Cited by 26 - Related articles - BL Direct - All 3 versions
- ►80.35.244.216 [PDF] ZF Bashshur, ZA Haddad, A Schakal, RF … - American Journal of Ophthalmology, 2007 - Elsevier Sixty patients (60 eyes) with subfoveal choroidal neovascular membrane (CNV)
attributable to AMD participated in this study at the American University of
Beirut and Hotel Dieu de France Retina Clinics. All lesion types were ... Cited by 62 - Related articles - All 38 versions
